265 related articles for article (PubMed ID: 19056927)
1. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.
Gordon KJ; Kirkbride KC; How T; Blobe GC
Carcinogenesis; 2009 Feb; 30(2):238-48. PubMed ID: 19056927
[TBL] [Abstract][Full Text] [Related]
2. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
3. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck.
Xu T; Yu CY; Sun JJ; Liu Y; Wang XW; Pi LM; Tian YQ; Zhang X
Arch Med Res; 2011 Feb; 42(2):128-37. PubMed ID: 21565626
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes.
Grönroos E; Kingston IJ; Ramachandran A; Randall RA; Vizán P; Hill CS
Mol Cell Biol; 2012 Jul; 32(14):2904-16. PubMed ID: 22615489
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo.
Kleeff J; Maruyama H; Ishiwata T; Sawhney H; Friess H; Büchler MW; Korc M
Gastroenterology; 1999 May; 116(5):1202-16. PubMed ID: 10220513
[TBL] [Abstract][Full Text] [Related]
10. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1.
Chen X; Liao J; Lu Y; Duan X; Sun W
Pathol Oncol Res; 2011 Jun; 17(2):257-61. PubMed ID: 20848249
[TBL] [Abstract][Full Text] [Related]
11. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-2 suppresses invasiveness of TSU-Pr1 cells with the inhibition of MMP-9 secretion.
Kumagai T; Shimizu T; Takeda K
Anticancer Res; 2006; 26(1A):293-8. PubMed ID: 16475709
[TBL] [Abstract][Full Text] [Related]
13. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
14. C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation.
Zhao Y; Xiao M; Sun B; Zhang Z; Shen T; Duan X; Yu PB; Feng XH; Lin X
J Biol Chem; 2014 Sep; 289(38):26441-26450. PubMed ID: 25100727
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of TGF-β superfamily members and role of Smad1/5/9-signalling in chondral versus endochondral chondrocyte differentiation.
Dexheimer V; Gabler J; Bomans K; Sims T; Omlor G; Richter W
Sci Rep; 2016 Nov; 6():36655. PubMed ID: 27848974
[TBL] [Abstract][Full Text] [Related]
16. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
17. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
18. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1.
Kersten C; Sivertsen EA; Hystad ME; Forfang L; Smeland EB; Myklebust JH
BMC Immunol; 2005 May; 6():9. PubMed ID: 15877825
[TBL] [Abstract][Full Text] [Related]
19. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
20. BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK.
Liu J; Ben QW; Yao WY; Zhang JJ; Chen DF; He XY; Li L; Yuan YZ
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2541-9. PubMed ID: 22652796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
